The analysis of PBMCs, peri-lesions and tumor lesions from breast and gastrointestinal cancer patients has revealed increased levels of PD-1 expression on tumor-infiltrating ILC2 compared with non-tumoral control tissues [124]. This evidence concerns the gene PDCD1 and neoplasm.